A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to…
A experimental drug improved blood sugar and triggered significant weight loss in type 1 diabetes over four months without serious safety concerns.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Rebisufligene etisparvovec
First gene therapy for a rare genetic brain disorder showed potential to slow cognitive decline, though patients need careful monitoring for liver complications.
Standard additionImpact of Chatbot-Based Cognitive Training on Cognitive Function and…
Chatbot-guided brain training improved memory and slowed white-matter decline in healthy older adults over three months of practice.
Underserved or high-risk populationsCAR T-cell therapy referral patterns and utilization for…
CAR-T therapy recipients experienced longer delays before needing additional treatment, though only a small fraction of eligible patients currently access it.
Standard additionOmission of Radiation Therapy is Associated with Inferior Disease…
Adding radiation to chemotherapy improved disease control for bulky lymphomas, though survival remained similar and late side effects increased.